Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | OLMA Olema Oncology, Inc. | 13G/A | 8.2% | Mar 31, 2026 | 6mo |
| LAZARD ASSET MANAGEMENT LLC | TDF Templeton Dragon Fund Inc | 13G | 7.3% | Mar 31, 2026 | 6mo |
| Kerry Propper | RDAC Rising Dragon Acquisition Corp. | 13G/A | 2.3% | Mar 31, 2026 | 6mo |
| Arena Investors LP | UCAR U Power Ltd | 13G/A | 0% | Mar 31, 2026 | 6mo |
| SC US (TTGP), LTD. | LIFE Ethos Technologies Inc. | 13G | 27.8% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | SLNO Soleno Therapeutics Inc | 13G/A | 2% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | KPRX Kiora Pharmaceuticals Inc | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| GATE CITY CAPITAL MANAGEMENT, LLC | SEG Seaport Entertainment Group Inc. | 13G | 5.4% | Mar 31, 2026 | 6mo |
| BARCLAYS PLC | ALF Centurion Acquisition Corp. | 13G | 7% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | OPFI OppFi Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| Global X Management CO LLC | TITN Titan Machinery Inc. | 13G/A | 9.59% | Mar 31, 2026 | 6mo |
| Judith A. Christian | SGA Saga Communications Inc | 13G/A | 13.9% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | IMMX Immix Biopharma, Inc. | 13G/A | 9.1% | Mar 31, 2026 | 6mo |
| Saba Capital Management, L.P. | PDX PIMCO Dynamic Income Strategy Fund | 13G/A | 14.35% | Mar 31, 2026 | 6mo |
| TD SECURITIES (USA) LLC | DYNC Dynamix Corp | 13G/A | 3.8% | Mar 31, 2026 | 6mo |
| Merus Global Investments, LLC | MRLN Merlin, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Vestal Point Capital, LP | DAWN Day One Biopharmaceuticals, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Xiao Wenjie | LX LexinFintech Holdings Ltd. | 13G/A | 25.8% | Mar 31, 2026 | 6mo |
| 1607 Capital Partners, LLC | EEA European Equity Fund, Inc | 13G/A | 20.77% | Mar 31, 2026 | 6mo |
| Sculptor Capital LP | CEPS Cantor Equity Partners VI, Inc. | 13G/A | 4.43% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | CPAY Corpay, Inc. | 13G/A | 7.5% | Mar 31, 2026 | 6mo |
| Global X Management CO LLC | WSTRF Western Uranium & Vanadium Corp. | 13G | 6.56% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | DYN Dyne Therapeutics, Inc. | 13G/A | 18.7% | Mar 31, 2026 | 6mo |
| Manulife Investment Management (US) LLC | RVSB Riverview Bancorp Inc | 13G/A | 5.17% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | PWCM Powercompute, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | HCAC Hall Chadwick Acquisition Corp | 13G | 0% | Mar 31, 2026 | 6mo |
| BlueCrest Capital Management Ltd | CRTO Criteo S.A. | 13G | 4.5% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | SBCF Seacoast Banking Corp Of Florida | 13G/A | 5% | Mar 31, 2026 | 6mo |
| Venrock Healthcare Capital Partners III, L.P. | ORIC Oric Pharmaceuticals, Inc. | 13G/A | 4.2% | Mar 31, 2026 | 6mo |
| BARCLAYS PLC | CHACR Crane Harbor Acquisition Corp. | 13G/A | 0.01% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | HUBS Hubspot Inc | 13G/A | 8.7% | Mar 31, 2026 | 6mo |
| Saba Capital Management, L.P. | EVTL Vertical Aerospace Ltd. | 13G/A | 12.02% | Mar 31, 2026 | 6mo |
| MSD Partners, L.P. | LIND Lindblad Expeditions Holdings, Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | WCC Wesco International Inc | 13G/A | 7.4% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | CZR Caesars Entertainment, Inc. | 13G/A | 6.02% | Mar 31, 2026 | 6mo |
| Bay Pond Partners, L.P. | BCML BayCom Corp | 13G/A | 4.9% | Mar 31, 2026 | 6mo |
| Verve Capital Limited | VOR Vor Biopharma Inc. | 13G/A | 9.3% | Mar 31, 2026 | 6mo |
| Arini Captial Management Ltd | SABR Sabre Corp | 13G/A | 9.26% | Mar 31, 2026 | 6mo |
| No Street GP LP | APEI American Public Education Inc | 13G/A | 3.5% | Mar 31, 2026 | 6mo |
| Xiangmin Cui | EQ Equillium, Inc. | 13G/A | 8.9% | Mar 31, 2026 | 6mo |
| Oaktree Capital Holdings, LLC | RILY BRC Group Holdings, Inc. | 13G/A | 4.7% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | CGON CG Oncology, Inc. | 13G | 8% | Mar 31, 2026 | 6mo |
| TORONTO DOMINION BANK | PTCT Ptc Therapeutics, Inc. | 13G/A | 3.7% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | DWTX Dogwood Therapeutics, Inc. | 13G | 9.99% | Mar 31, 2026 | 6mo |
| BAMCO INC /NY/ | KNSL Kinsale Capital Group, Inc. | 13G/A | 8.76% | Mar 31, 2026 | 6mo |
| Rubric Capital Management LP | PRTA Prothena Corp Public Ltd Co | 13G/A | 9.29% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | SSAC SPACSphere Acquisition Corp. | 13G | 7.6% | Mar 31, 2026 | 6mo |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | CMU Mfs High Yield Municipal Trust | 13G/A | 11.6% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | CLH Clean Harbors Inc | 13G/A | 6.8% | Mar 31, 2026 | 6mo |
| Solas Capital Management, LLC | MODD Modular Medical, Inc. | 13G/A | 9.6% | Mar 31, 2026 | 6mo |